Stocks
Quest Diagnostics Incorporated (DGX) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 3 159 | 1 820 | 1 732 | 1 894 | 2 194 | 1 980 | ||
| Changes by years, y/y, % | +31% | -42% | -5% | +9% | +16% | -1.9% | |||
Quest Diagnostics Incorporated. EBITDA US GAAP, bln rub
Quest Diagnostics Incorporated. EBITDA US GAAP, changes, %
Quest Diagnostics Incorporated. EBITDA US GAAP, sum by quarters, bln rub
Quest Diagnostics Incorporated (DGX) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 488.0 | 596.0 | 547.0 | 401.0 | 436.0 | 1 980 | |
| Changes by years, y/y, % | +13% | +25% | +14% | -21% | -11% | |||
| Changes by quarters, q/q, % | -4% | +22% | -8% | -27% | +9% | |||
